277 related articles for article (PubMed ID: 26865616)
1. Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway.
Hartz AM; Zhong Y; Wolf A; LeVine H; Miller DS; Bauer B
J Neurosci; 2016 Feb; 36(6):1930-41. PubMed ID: 26865616
[TBL] [Abstract][Full Text] [Related]
2. Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model.
Ding Y; Zhong Y; Baldeshwiler A; Abner EL; Bauer B; Hartz AMS
Fluids Barriers CNS; 2021 Mar; 18(1):10. PubMed ID: 33676539
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model.
Vulin M; Zhong Y; Maloney BJ; Bauer B; Hartz AMS
Fluids Barriers CNS; 2023 Oct; 20(1):70. PubMed ID: 37803468
[TBL] [Abstract][Full Text] [Related]
4. Preventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer's Disease Mouse Model.
Hartz AMS; Zhong Y; Shen AN; Abner EL; Bauer B
Front Aging Neurosci; 2018; 10():186. PubMed ID: 29997495
[TBL] [Abstract][Full Text] [Related]
5. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
6. New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models.
Chai AB; Hartz AMS; Gao X; Yang A; Callaghan R; Gelissen IC
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383667
[TBL] [Abstract][Full Text] [Related]
7. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.
Hartz AM; Miller DS; Bauer B
Mol Pharmacol; 2010 May; 77(5):715-23. PubMed ID: 20101004
[TBL] [Abstract][Full Text] [Related]
8. Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling.
Park R; Kook SY; Park JC; Mook-Jung I
Cell Death Dis; 2014 Jun; 5(6):e1299. PubMed ID: 24967961
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK
Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
Chai AB; Leung GKF; Callaghan R; Gelissen IC
FEBS J; 2020 Feb; 287(4):612-625. PubMed ID: 31750987
[TBL] [Abstract][Full Text] [Related]
11. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
[TBL] [Abstract][Full Text] [Related]
12. Transport of Alzheimer's associated amyloid-β catalyzed by P-glycoprotein.
McCormick JW; Ammerman L; Chen G; Vogel PD; Wise JG
PLoS One; 2021; 16(4):e0250371. PubMed ID: 33901197
[TBL] [Abstract][Full Text] [Related]
13. ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy.
Carrano A; Snkhchyan H; Kooij G; van der Pol S; van Horssen J; Veerhuis R; Hoozemans J; Rozemuller A; de Vries HE
Neurobiol Aging; 2014 Mar; 35(3):565-75. PubMed ID: 24138987
[TBL] [Abstract][Full Text] [Related]
14. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
Kuhnke D; Jedlitschky G; Grube M; Krohn M; Jucker M; Mosyagin I; Cascorbi I; Walker LC; Kroemer HK; Warzok RW; Vogelgesang S
Brain Pathol; 2007 Oct; 17(4):347-53. PubMed ID: 17610523
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo study of dolichyl phosphate on the efflux activity of P-glycoprotein at the blood-brain barrier.
Ji BS; Cen J; Liu L; He L
Int J Dev Neurosci; 2013 Dec; 31(8):828-35. PubMed ID: 24161469
[TBL] [Abstract][Full Text] [Related]
16. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
[TBL] [Abstract][Full Text] [Related]
17. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
[TBL] [Abstract][Full Text] [Related]
18. Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.
Qosa H; LeVine H; Keller JN; Kaddoumi A
Biochim Biophys Acta; 2014 Sep; 1842(9):1806-15. PubMed ID: 24997450
[TBL] [Abstract][Full Text] [Related]
19. The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer's disease.
Kirabali T; Rigotti S; Siccoli A; Liebsch F; Shobo A; Hock C; Nitsch RM; Multhaup G; Kulic L
Acta Neuropathol Commun; 2019 Dec; 7(1):194. PubMed ID: 31796114
[TBL] [Abstract][Full Text] [Related]
20. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.
Vogelgesang S; Cascorbi I; Schroeder E; Pahnke J; Kroemer HK; Siegmund W; Kunert-Keil C; Walker LC; Warzok RW
Pharmacogenetics; 2002 Oct; 12(7):535-41. PubMed ID: 12360104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
